SEATTLE, Aug. 4, 2022 /PRNewswire/ -- Volpara Health Technologies ("Volpara," "the Group," or "the Company"; ASX: VHT), a global health technology software leader providing an integrated platform for ...
GROTON, Conn.--(BUSINESS WIRE)--Following a rigorous selection process, Volpara Health, a global leader in software for the early detection and prevention of cancer, announced today that it has ...
Research from Mayo Clinic and UCSF find that the combination of Transpara ® Exam Score with Volpara TruDensity® can predict long-term risk of invasive breast cancers The study was designed to ...
Pairing the AI computer-aided-detection system Transpara™ with Volpara volumetric density assessment improved screening efficacy for women with dense breast tissue compared to a traditional double ...
Wellington-based Volpara Health Technologies is a research, development and manufacturing company specialising in breast imaging analytics and in-clinic analysis products that measure breast density.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results